SV7 Impact Medicine Fund LP 13D and 13G filings for Xilio Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-03 4:19 pm Purchase |
2021-10-26 | 13D | Xilio Therapeutics, Inc. XLO |
SV7 Impact Medicine Fund LP | 1,613,632 6.050% |
1,613,632 (New Position) |
Filing |